British biopharmaceutical giant AstraZeneca plans to invest $50 billion in the United States by 2030, expanding its presence ...

AstraZeneca plans to spend $50 billion to expand manufacturing and research capabilities in the U.S. by 2030, it said on ...

The Memphis Grizzlies are evaluating centers and forwards for a two-way spot this summer, but have any of them impressed ...

Sarepta Therapeutics, Inc. ( NASDAQ: SRPT) Strategic Restructure and ELEVIDYS Label Update Conference Call July 16, 2025 4:30 PM ET Douglas S. Ingram - President, CEO & Director Ian Estepan - ...

The most valuable lesson from our growth trajectory came about a year in, when we faced a jarring reality: While our marketing and lead generation systems were working great in some territories, other ...

Columnist Chris Herrington and Grizzlies beat reporter Drew Hill discuss summer league and players who could be competing for two-way contracts.

This is all just going away,” host Stephen Colbert said while taping his Thursday show.

From J&J to BMS, New Jersey pharmaceutical companies continue to expand and transform through M&A, leadership shifts and ...

Your next option is to become an owner/operator of your franchise business. If you’re someone who wants to be fully involved in everyday operations, this is typically the best path for you. As an ...

Johnson & Johnson stands alone as a leader across the major healthcare industries. It maintains a diverse revenue base, a developing research pipeline, and exceptional cash flow generation that ...

A business that has the potential to be sold as a franchise opportunity, generally having the following characteristics: It is established, offers a unique concept, is teachable and can provide an ...